Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biogen
biotech
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
celgene
4
×
detroit blog main
detroit top stories
indiana blog main
indiana top stories
ipo
4
×
life sciences
national
national blog main
national top stories
new york blog main
new york top stories
novartis
4
×
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
gene therapy
medicare
pfizer
amgen
cancer
car-t
crispr
deals
donald trump
What
bio
roundup
gene
allogene
alzheimer’s
august
becker
billions
biotech
busy
cancer
companies
crispr
days
decisions
devices
different
diversity
dollars
drug
drugs
eaton
fail
fda
healthcare
hot
immunotherapy
impact
increases
investors
ipo
juno
latest
legacy
life
michael
million
millions
moves
nearly
Language
unset
Current search:
celgene
×
novartis
×
ipo
×
@xconomy.com
4 years ago
Bio Roundup: Sarepta’s Stumble, Opioid Suits, Shkreli’s Legacy & More
@xconomy.com
4 years ago
Bio Roundup: Michael Becker, Suzanne Eaton, Gene Therapy Moves & More
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Fail, Drug Price Plan, Gene Therapies & More
@xconomy.com
5 years ago
Bio Roundup: BIO Diversity, Allogene IPO, CRISPR In Utero & More